Further Electrochemical and Behavioural Evidence of a Direct Relationship Between Central 5-HT and Cytoskeleton in the Control of Mood.
Reduced activity of CNS serotonin is reported in unipolar depression and serotonin is the major target of recent antidepressant drugs. However, an acute depletion of serotonin in healthy individuals does not induce depressive symptoms suggesting that depression does not correlate with the serotonin system only. Neuronal plasticity (structural adaptation of neurons to functional requirements) includes synthesis of microtubular proteins such as tyrosinated isoform of alpha-tubulin and presence of serotonin as regulator of synaptogenesis. In depression neuronal plasticity is modified.HERE, IN RATS SUBMITTED TO A BEHAVIOURAL TEST WIDELY USED TO PREDICT THE EFFICACY OF ANTIDEPRESSANT DRUGS (FORCED SWIMMING TEST: FST) a significant decrease of both cerebral tyrosinated alpha-tubulin expression and serotonin levels is monitored. Moreover, treatment with para-chlorophenylalanine (PCPA, compound that specifically depletes brain serotonin) but not alpha-methyl para tyrosine (alpha-MPT, compound that blocks synthesis of catechols: chemicals also implicated in depression) significantly reduced tyrosinated alpha-tubulin. Thus, a direct relationship between serotonin and tyrosinated alpha-tubulin appears to be present both in "physiological" and in "pathological" states. In addition, data obtained in animals submitted to FST and/or treated with the selective serotonin reuptake inhibitor (SSRI) fluoxetine further support the interrelationship between central serotonin and cytoskeleton. These data propose that direct relationship between serotonin and tyrosinated alpha-tubulin could be considered within the mechanism(s) involved in the pathogenesis of depression.
Crespi
Francesco
F
Biology Department, Neurosciences CEDD GlaxoSmithKline, Medicines Research Centre, via Fleming 4, 37135 Verona, Italy.
Biol Psychiatry. 2006 Jun 15;59(12):1136-43
16797263
Pharmacol Biochem Behav. 1995 Sep;52(1):107-12
7501651
Behav Brain Res. 2009 Dec 28;205(2):518-24
19683020
Hum Psychopharmacol. 2008 Dec;23(8):647-51
18821727
J Neurosci Methods. 1994 Sep;54(1):75-82
7815821
J Neurosci Methods. 1990 Sep;34(1-3):53-65
1979651
J Pharmacol Exp Ther. 1966 Dec;154(3):499-516
5297133
Neuromolecular Med. 2004;5(1):11-25
15001809
Neurochem Res. 2007 Sep;32(9):1559-65
17486443
Biol Psychiatry. 2000 Oct 15;48(8):732-9
11063970
J Cell Biol. 1984 Jan;98(1):347-51
6707095
J Affect Disord. 2006 Oct;95(1-3):119-23
16782204
Ann N Y Acad Sci. 1990;600:297-313; discussion 314
2252317
Sensors (Basel). 2008 Nov 04;8(11):6936-6951
27873908
Brain Res. 2003 Jun 13;975(1-2):244-7
12763614
Neuropsychopharmacology. 1994 Jul;10(4):231-8
7945733
Nucl Med Biol. 1999 Jan;26(1):91-8
10096507
Psychopharmacology (Berl). 2006 Jun;186(3):362-72
16432684
Hum Psychopharmacol. 2004 Aug;19(6):405-8
15303244
Int Rev Cytol. 1989;114:21-79
2661457
Hum Psychopharmacol. 2000 Jul;15(5):315-336
12404310
J Neurochem. 1992 Jan;58(1):250-7
1370077
Cell. 1991 Feb 22;64(4):817-26
1997209
Psychopharmacology (Berl). 2003 Jan;165(2):97-110
12420152
Biol Psychiatry. 2006 Feb 15;59(4):309-16
16154542
Behav Brain Res. 1996;73(1-2):43-6
8788475
Neuroscience. 1988 Dec;27(3):885-96
3252175
Psychopharmacology (Berl). 1986;89(4):467-71
2428076
J Cell Biol. 1987 Jul;105(1):251-64
2886509
Neurosci Lett. 2001 Oct 12;312(1):5-8
11578832
FEBS Lett. 2003 Jan 30;535(1-3):183-9
12560101
Synapse. 1999 Mar 15;31(4):285-9
10051109
J Neurosci. 2003 Aug 6;23(18):6972-81
12904458
Curr Opin Cell Biol. 1994 Feb;6(1):74-81
8167029
Psychopharmacology (Berl). 1995 Sep;121(1):66-72
8539342
Nature. 1977 Apr 21;266(5604):730-2
559941
Eur J Pharmacol. 1997 Aug 27;333(2-3):279-87
9314045
Biochem J. 1999 Apr 15;339 ( Pt 2):463-71
10191280
Neurochem Res. 2000 Jan;25(1):27-36
10685601
Proc Natl Acad Sci U S A. 2006 Mar 21;103(12):4711-6
16537405
Prog Neurobiol. 2003 Dec;71(6):401-37
15013227
Biol Psychiatry. 2008 Aug 15;64(4):293-301
18406399
Eur J Pharmacol. 1997 Oct 15;337(1):111-4
9389388
Rev Neurosci. 2005;16(1):23-41
15810652
Science. 1985 Oct 11;230(4722):181-3
3875898
Trends Pharmacol Sci. 1994 Jul;15(7):220-6
7940983
Eur J Histochem. 1999;43(4):285-91
10682266
Crit Rev Neurobiol. 2004;16(1-2):67-74
15581401
Int J Neuropsychopharmacol. 2005 Mar;8(1):1-4
15710052
Biol Psychiatry. 2004 Aug 1;56(3):140-5
15271581
Int Rev Cytol. 1998;178:207-75
9348671
Schizophr Res. 1998 Mar 10;30(2):115-25
9549774
J Neurochem. 2000 Jan;74(1):21-33
10617102
Psychopharmacology (Berl). 1990;100(4):509-14
2320712
Prog Neuropsychopharmacol Biol Psychiatry. 2005 Feb;29(2):169-92
15694225